Life Technologies Buys Certain Assets of Indian Firm Labindia | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced a definitive agreement to buy certain assets from Indian firm Labindia for an undisclosed amount.

Labindia has been a distributor of Life Tech's Applied Biosystems products, including the SOLiD sequencing system and Ambion RNA reagents, since 1994. The deal creates a full service business, allowing Life Tech to supply ABI and Invitrogen products directly to customers, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.